Preferred Stock Purchase Rights
- Symbol
- No trading symbol declared
- Exchange
- NASDAQ
- Classification
- RIGHT
Current Report · Items 8.01, 9.01 · 8-K
Seer, Inc.
SEERNASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On July 2, 2026, Seer, Inc. (the “Company”) issued a press release announcing the receipt of an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class A common stock for $2.45 per share in cash plus two separate contingent value rights.…
Press release in this filing
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. →Company context
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with a scale, speed, precision and reproducibility previously unattainable. Seer’s Proteograph® Product Suite integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables and advanced analytical software to overcome the limitations of traditional proteomic methods. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.
Current securities
Recent company filings
- Other EventsOct 29, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 18, 2026
- 10-Q filingAug 11, 2026
- Results of Operations and Financial ConditionAug 11, 2026
- Submission of Matters to a Vote of Security HoldersJul 31, 2026
Registered securities in this filing
Seer, Inc. · 8-K · Filed 2026-07-02
Class A Common Stock, par value $0.00001 per share
- Symbol
- SEER
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On July 2, 2026, Seer, Inc. (the “Company”) issued a press release announcing the receipt of an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class A common stock for $2.45 per share in cash plus two separate contingent value rights. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
A copy of the letter received from Dr. Farokhzad concerning his proposal is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
Filed exhibits (2)
EX-99.1 2 ck0001726445-ex99_1.htm EX-99.1 EX-99.1 Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. No Stockholder Action Required at This Time REDWOOD CITY, Calif. - July 2, 2026 - Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class A common stock for $2.45 per share in cash plus two separate contingent value rights (the “Proposal”). The full text of the letter received from Dr. Farokhzad outlining the Proposal will be included on a Form 8-K filing made by Seer. Seer’s Board of Directors will establish a Special Committee consisting solely of independent directors. The Special Committee will evaluate the Proposal and other alternatives available to Seer, and determine the course of action that it believes is in the best interests of Seer and its stockholders. The Special Committee will retain independent financial and legal advisors to assist it with its work. No stockholder action is required at…
Open exhibit ↗EX-99.2 3 ck0001726445-ex99_2.htm EX-99.2 EX-99.2 Omid Farokhzad, M.D. Chief Executive Officer Seer, Inc. 3800 Bridge Parkway, Redwood City, CA 94065 July 1, 2026 CONFIDENTIAL - DELIVERED PERSONALLY The Board of Directors Seer, Inc. 3800 Bridge Parkway, Redwood City, CA 94065 Attention: Lead Independent Director and Members of the Board of Directors Re: Proposal to Take Seer, Inc. Private at $2.45 per Share in Cash Plus Two Contingent Value Rights Dear Members of the Board: After careful reflection, I am writing in my personal capacity as a stockholder of Seer, Inc. (the “Company”) - and not in my capacity as Chairman of the Board of Directors and Chief Executive Officer - to submit a non-binding proposal to acquire all of the outstanding shares of common stock of Seer, Inc. (the “Company”) that I do not already own (the “Proposal”). The Proposal consists of $2.45 per share in cash, plus two separate Contingent Value Rights (“CVRs”): (i) a tiered Revenue-Linked CVR of up to $0.25 per share tied to a defined revenue milestone; and (ii) a tiered Sale-Linked CVR of up to $2.91 per share tied to a future sale, license, or strategic disposition of the Company or its core ass…
Open exhibit ↗